The Dasatinib n/a (Catalog #MBS6074429) is a Biochemical produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Dasatinib, also known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinases inhibitor approved for use in patients with chronic myelogenous leukemia (CML) after imatinib treatment and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is also being assessed for use in metastatic melanoma.
CAS Number: 302962-49-8 Molecular Formula: C22H26ClN7O2S Residue on ignition: 0.2% Heavy Metals: 0.002%. Method for Determining Identity: Proton NMR Spectroscopic Analysis, HPLC Solubility: Insoluble in water and slightly soluble in ethanol and methanol.